StocksBruker CorpBRKR

BRKR

Bruker Corp

64.64 -2.97 (-4.39%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
64.58
B
64.74

Overview

Prev Close64.64
Day's Range63.40 - 65.97
52 Week Range54.39 - 91.95
Average Volume (3m)1.08M
1-Year Return10.38%
Beta1.1215
Market Cap9.8B
P/E Ratio36.63
Revenue2.36B
EPS1.7648
Dividend (Yield)0.16 (0.25%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.711/08/202125/10/202105/01/202265.0070.0075.0080.0085.0090.0095.00
Chart times in UTC
Industry Medical Specialties
CEO Frank H. Laukien, PhD
Employees 7,400

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: Bruker Corp's revenues decreased by 4.11% and amounted to 1.99B. Net income decreased by 18.48% to 161.40M. Net assets increased by 3.85% to 974.30M and EPS decreased from 1.26 to 1.02.
BRKR's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
50.17%
Net Profit Margin
7.85%
Operating Margin
17.95%
Return On Investment
10.33%
12/20
03/21
06/21
09/21
Total Revenue
627.5M
554.7M
570.8M
608.9M
Gross Profit
315.5M
278.7M
280.6M
308.7M
Operating Income
127.6M
89.1M
85.6M
113.2M
Net Income
71.3M
57.8M
58.7M
88.1M